China's biological influenza virus split vaccine has passed WHO pre certification
AD |
According to the official WeChat account of China Biotech, on October 20, 2023, the influenza virus split vaccine produced by China National Pharmaceutical Group Changchun Institute of Biological Products passed the pre certification of the World Health Organization (WHO). As the first influenza vaccine in China to pass the pre certification of the World Health Organization, it marks that the production, manufacturing, and quality management level of China's biological influenza vaccine has been at the forefront of the world
According to the official WeChat account of China Biotech, on October 20, 2023, the influenza virus split vaccine produced by China National Pharmaceutical Group Changchun Institute of Biological Products passed the pre certification of the World Health Organization (WHO). As the first influenza vaccine in China to pass the pre certification of the World Health Organization, it marks that the production, manufacturing, and quality management level of China's biological influenza vaccine has been at the forefront of the world. Not only has China made outstanding contributions to domestic influenza prevention and control, but also contributed to building a global health barrier.
The influenza virus split vaccine produced by Changchun Institute of Biological Products has officially launched the pre certification work of the World Health Organization since 2015, and has undergone comprehensive and in-depth benchmarking with the latest international regulations and guidelines. After process changes and continuous optimization, the product quality standards have been continuously improved. In September 2018, the pre certification application materials of the World Health Organization were submitted; And complete on-site inspection in 2022.
The influenza virus split vaccine produced by Changchun Institute of Biological Products is made by inoculating chicken embryos with epidemic strains recommended by the World Health Organization. After cultivation, harvesting of virus solution, virus purification, splitting, re purification, and inactivation, it is produced. Its production process is stable, and the production process is always under control. It can continuously produce influenza vaccines with good consistency, and all quality standards are higher than those of the Chinese Pharmacopoeia and European Pharmacopoeia, fully ensuring the quality, safety, and effectiveness of influenza vaccines.
Editor Liu Jiani
Disclaimer: The content of this article is sourced from the internet. The copyright of the text, images, and other materials belongs to the original author. The platform reprints the materials for the purpose of conveying more information. The content of the article is for reference and learning only, and should not be used for commercial purposes. If it infringes on your legitimate rights and interests, please contact us promptly and we will handle it as soon as possible! We respect copyright and are committed to protecting it. Thank you for sharing.(Email:[email protected])
Mobile advertising space rental |
Tag: China biological influenza virus split vaccine has passed WHO
Supported by world-class scientific facilities, Shenzhen competes for a trillion yuan blue ocean of synthetic biology | Guangdong Research Tour on the 45th Anniversary of Reform and Opening up
NextWeChat quietly updates this feature! Netizens argue and fall out
Guess you like
- Detail
-
Apple iPhone 16 and Huawei Mate XT Tri-fold Phones Released on the Same Day: Who Will Win in a "Godly Battle" in Changsha Offline Stores?Detail
2024-09-21 16:18:55 1
- Detail
-
Has Your Personal Information Been Leaked? The Truth Behind Nuisance Calls and How to Protect YourselfDetail
2024-09-20 19:58:58 11
- Detail
-
iPhone 16 Debuts! Tmall Flagship Store's "More for the Same Price" Campaign Sparks Another Buying FrenzyDetail
2024-09-20 16:00:18 11
- Detail
- Detail
- Detail
-
Huawei's Tri-Fold Phone Gets "Bad Reviews": Chen Zhen Reviews with a Xiaomi Foldable and Says it's "Cool but I Probably Won't Use It Long-Term"Detail
2024-09-19 11:37:20 1
-
Python 3 Journey: 10 Lesser-Known Tips and Best Practices to Become a Better DeveloperDetail
2024-09-18 19:35:06 1
- Detail
- Detail
-
Is Buying a Phone Online Really Cheaper? A Physical Store Owner Reveals the "Inside Scoop": Stop Being Tricked!Detail
2024-09-18 16:46:11 1
- Detail
-
From a Stranger's Number to a Soul Mate: My Mobile Number "Inheritance" JourneyDetail
2024-09-16 03:06:20 11
-
Reproduction Under Weightlessness: How Can Humanity Perpetuate Civilization in Space?Detail
2024-09-15 23:18:12 11
- Detail
- Detail
-
41-Year-Old Academic President Passes Away, Leaving a 21-Character Message for His 4-Year-Old Son, Bringing Tears to Many Eyes!Detail
2024-09-15 15:21:49 1